| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0024 | 1 |